Accelerating Antibody Discovery for Complex Targets: Digital Platforms & AI Integration for GPCRs
- Digitalization and optimization of biotherapeutics discovery workflows accelerate identification of antibodies against challenging targets such as GPCRs
- Automated platforms leveraging integrated sequence, screening, and informatics data enable efficient selection from large, diverse antibody panels
- These advancements provide a foundation for AI/ML applications to address complex therapeutic targets such as GPCRs